November is National #FamilyCaregiversMonth. Stealth would like to thank and honor the selfless individuals who provide essential care and support to their loved ones. National Family Caregivers Month was established to recognize the significant contributions of family caregivers and to raise awareness about the challenges they face.?? ? Here are some helpful resources from Caregiver Action Network to support caregivers in juggling their many responsibilities while working to take care of their own wellbeing: https://lnkd.in/gXRwxhKr #FamilyCaregivers #SupportCaregivers #NFCMonth
Stealth BioTherapeutics
生物技术
Needham，Massachusetts 9,271 位关注者
Committed to Innovation in Mitochondrial Therapies
关于我们
Our Mission Stealth BioTherapeutics is an innovative biopharmaceutical company developing therapies to treat mitochondrial dysfunction associated with genetic mitochondrial diseases and common diseases of aging. Our team works with patients and advocacy organizations to better understand their journey and raise awareness of the unmet need our programs seek to address. We collaborate with top-tier academic and medical institutions, scientific thought leaders, and clinical key opinion leaders in developing the first generation of targeted therapies focusing on mitochondrial dysfunction as it presents in these rare genetic diseases and common diseases of aging. With these collaborative efforts, we continue to advance our platform of late-stage clinical programs and novel pipeline candidates. Please be aware of?the?potential for?scams claiming to represent Stealth BioTherapeutics in recruitment activities. Stealth exclusively uses @stealthbt.com e-mail addresses for recruitment purposes and does?not?conduct interviews via?social media or other third-party sites. Please report any suspicious recruiting activity to us at [email protected] and to the Internet Crime Complaint Center.
- 网站
-
https://www.stealthbt.com/
Stealth BioTherapeutics的外部链接
- 所属行业
- 生物技术
- 规模
- 51-200 人
- 总部
- Needham，Massachusetts
- 类型
- 私人持股
- 创立
- 2007
地点
-
主要
获取路线
123 Highland Ave
Suite 201
US，Massachusetts，Needham，02494
Stealth BioTherapeutics员工
动态
-
We’re right around the corner from the world's largest conference of ataxia researchers! Happening at #ICAR2024 in London, England, Stealth will be presenting new data on pre-clinical models in Friedreich’s ataxia (FA). Looking forward to an exciting conference!??https://lnkd.in/eemV2Q4E
-
-
Attending CNS Summit 2024? Be sure to tune in to the Medicines for Mito spotlight session to hear from Stealth CEO, Reenie McCarthy, alongside fellow life science leaders as they discuss the impact of mitochondrial disease and the potential of mitochondria-targeted therapeutics. #CNSummit2024 https://lnkd.in/g4wrh-gQ
-
-
We’re pleased to share that the results of ReCLAIM-2, our Phase 2 study in dry age-related macular degeneration (AMD) with non-central geographic atrophy, were recently published in Ophthalmology Science, a peer-reviewed journal of the American Academy of Ophthalmology. Key learnings from ReCLAIM-2 informed our Phase 3 program, including the ongoing ReNEW study which is currently enrolling participants. Read the publication here: https://lnkd.in/eU-XNgqy?
-
-
Congrats to Dr. Hilary Vernon for being named a 2024 RARE Champion of Hope! Thank you for your continued work and championing in the rare and ultra-rare disease communities!?
Global Genes is pleased to announce the winners of our 2024 RARE Champions of Hope! See our blog post below to read more about each individual and their background. Congratulations, all! Thank you for all of your incredible work in the rare disease community! ???? #WeekInRARE #RAREAdvocacySummit #RAREChampionsOfHope #COH https://lnkd.in/gu2N_G_W
-
-
The American Academy of Ophthalmology Annual Meeting starts this week in Chicago! We’re looking forward to sharing the latest on our clinical development program for dry age-related macular degeneration (AMD). #EyesOnMito #AAO24??
-
We were incredibly moved by the testimonials shared by the #BarthSyndrome community – including patients, caregivers, advocates, and healthcare providers – at yesterday’s advisory committee meeting. We are inspired by their perseverance to advocate for themselves and their loved ones and to shine a light on the tremendous unmet need faced by those with this rare #MitochondrialDisease. We remain committed to supporting and standing with this community.
-
-
NEWS: An update on the outcome from the FDA Advisory Committee Meeting on our investigational therapy for Barth syndrome. Read more here:?https://prn.to/402CRTq
-
-
In case you missed it, our CEO, Reenie McCarthy, participated in a fireside chat at the UBS Virtual Ophthalmology Day yesterday. Watch the full recording here to learn more about our program in #DryAMD: https://lnkd.in/ey3UPwqy
-
-
Members of the Stealth team had a great time at the MitoAction Energy Walk this past weekend in Boston, MA! ?It's always inspiring to see the mito community come together and we are extremely grateful for MitoAction’s partnership. Learn more about MitoAction & their work at https://lnkd.in/gA76-RKe
-